Newron Pharmaceuticals SpA (NWRN) — Financial Flexibility Index
Newron Pharmaceuticals SpA (NWRN) has a Financial Flexibility Index of -0.03x as of December 2025. Free cash flow of CHF-1.31 Million (operating CF CHF-1.33 Million minus capex CHF15.73K) represents 0% of total liabilities (CHF51.15 Million). Check NWRN capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Newron Pharmaceuticals SpA Financial Flexibility Index (2005–2025)
Historical Financial Flexibility Index trend for Newron Pharmaceuticals SpA across 21 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Newron Pharmaceuticals SpA.
Annual Financial Flexibility Index for Newron Pharmaceuticals SpA (2005–2025)
Year-by-year free cash flow to debt coverage for Newron Pharmaceuticals SpA. Explore Newron Pharmaceuticals SpA (NWRN) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CHF) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.64x | CHF32.61 Million | CHF32.56 Million | CHF51.15 Million | ▲ +326.2% |
| 2024 | -0.28x | CHF-17.60 Million | CHF-17.61 Million | CHF62.45 Million | ▼ -55.2% |
| 2023 | -0.18x | CHF-10.13 Million | CHF-10.14 Million | CHF55.77 Million | ▲ +16.0% |
| 2022 | -0.22x | CHF-11.07 Million | CHF-11.09 Million | CHF51.23 Million | ▲ +10.3% |
| 2021 | -0.24x | CHF-11.43 Million | CHF-11.45 Million | CHF47.38 Million | ▲ +47.4% |
| 2020 | -0.46x | CHF-15.55 Million | CHF-15.59 Million | CHF33.95 Million | ▲ +50.9% |
| 2019 | -0.93x | CHF-21.93 Million | CHF-21.98 Million | CHF23.49 Million | ▲ +69.7% |
| 2018 | -3.08x | CHF-15.92 Million | CHF-15.95 Million | CHF5.16 Million | ▼ -95.1% |
| 2017 | -1.58x | CHF-8.38 Million | CHF-8.40 Million | CHF5.30 Million | ▲ +44.6% |
| 2016 | -2.85x | CHF-19.51 Million | CHF-19.58 Million | CHF6.84 Million | ▼ -61.9% |
| 2015 | -1.76x | CHF-12.80 Million | CHF-12.86 Million | CHF7.27 Million | ▼ -37.9% |
| 2014 | -1.28x | CHF-9.98 Million | CHF-10.00 Million | CHF7.81 Million | ▼ -26.8% |
| 2013 | -1.01x | CHF-10.61 Million | CHF-10.69 Million | CHF10.53 Million | ▼ -394.2% |
| 2012 | 0.34x | CHF5.84 Million | CHF5.83 Million | CHF17.04 Million | ▲ +148.4% |
| 2011 | -0.71x | CHF-4.94 Million | CHF-4.94 Million | CHF6.98 Million | ▲ +74.3% |
| 2010 | -2.75x | CHF-19.12 Million | CHF-19.13 Million | CHF6.94 Million | ▼ -48.5% |
| 2009 | -1.85x | CHF-22.99 Million | CHF-23.06 Million | CHF12.39 Million | ▼ -39.6% |
| 2008 | -1.33x | CHF-19.57 Million | CHF-19.93 Million | CHF14.73 Million | ▼ -27.4% |
| 2007 | -1.04x | CHF-13.53 Million | CHF-13.87 Million | CHF12.97 Million | ▼ -99.3% |
| 2006 | -0.52x | CHF-9.58 Million | CHF-9.63 Million | CHF18.30 Million | ▲ +76.2% |
| 2005 | -2.20x | CHF-14.23 Million | CHF-14.33 Million | CHF6.48 Million | — |